Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alkermes (ALKS) EBITDA (2016 - 2026)

Alkermes has reported EBITDA over the past 16 years, most recently at $48.3 million for Q4 2025.

  • Quarterly EBITDA fell 66.48% to $48.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $241.5 million through Dec 2025, down 34.4% year-over-year, with the annual reading at $241.5 million for FY2025, 34.4% down from the prior year.
  • EBITDA was $48.3 million for Q4 2025 at Alkermes, down from $83.1 million in the prior quarter.
  • Over five years, EBITDA peaked at $237.8 million in Q2 2023 and troughed at -$66.3 million in Q3 2022.
  • The 5-year median for EBITDA is $29.7 million (2024), against an average of $37.9 million.
  • Year-over-year, EBITDA crashed 6840.9% in 2022 and then surged 834.04% in 2023.
  • A 5-year view of EBITDA shows it stood at -$379000.0 in 2021, then crashed by 6840.9% to -$26.3 million in 2022, then soared by 539.99% to $115.7 million in 2023, then rose by 24.51% to $144.1 million in 2024, then plummeted by 66.48% to $48.3 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's EBITDA are $48.3 million (Q4 2025), $83.1 million (Q3 2025), and $87.2 million (Q2 2025).